期刊文献+

思连康治疗婴幼儿轮状病毒肠炎206例临床分析 被引量:5

Effect of si-lian-kang on rotavirus enteritis of infants and young children
下载PDF
导出
摘要 目的:探讨思连康治疗婴幼儿轮状病毒肠炎的疗效。方法:206例婴幼儿轮状病毒肠炎患儿随机分为两组,对照组给予静脉滴喜炎平注射液,口服思密达;治疗组在此基础上口服思连康(<6个月,2次/d,每次1片;~1岁,2次/d,每次2片;~3岁,2~3次/d,每次2片),观察两组的总有效率、止吐时间、退热时间、止泻时间和总疗程。结果:治疗组总有效率(92.5%)明显高于对照组(78.0%),退热、止泻、总疗程较对照组明显缩短,差异均有统计学意义(P<0.05),两组止吐时间差异无统计学意义(P>0.05)。结论:思连康对婴幼儿轮状病毒肠炎有良好的疗效,值得临床推广使用。 Objective: To investigate the effect of si-lian-kang on the treatment of rotavirus enteritis of infants and young children. Methods: Two hundred and six infants and young children patients with ratovirus enteritis were divided ramdonly, into two groups (group A and B) , patients in group B were treated with xiyanping injection and oral smecta, patients in group A were treated with si-lian-kang (patients 〈 6 months, 1 tablet each time, 2 times daily; - 1-year-old, 2 tablets each time, 2 times daily; - 3 years old, 2 tablets each time, 2 -3 times daily) on the basis of therapy with xiyanping injection and oral smeeta;overall effective rate, afebrile time, time of vomiting stopping and diarrhea stopping, and therapy course were evaluated. Results: The overall effective rate of group B and A was 92.5% and 78% respectively, afebrile time, time of diarrhea stopping and therapy course in group B were significant shorter than that in group A (P 〈 0.05 ) , there was no significant difference between the two groups for the time of vomiting stopping (P 〉 0.05). Conclusion : Si-lian-kang has good effect on the treatment of rotavirus enteritis of infants and young children.
出处 《海南医学院学报》 CAS 2009年第8期942-943,947,共3页 Journal of Hainan Medical University
基金 海南医学院科研基金资助学报项目(0020090109)~~
关键词 思连康 婴幼儿 轮状病毒 肠炎 Si-lian-kang Infants and young children Rotavirus Enteritis
  • 相关文献

参考文献4

二级参考文献19

  • 1[1]Lilly DM,Stillwell RH.Probiotics.Growth promoting factors produced by micro-organisms.[J]Science,1965,147:747-948.
  • 2[2]Fuller R.Probiotics in man and animal [J] J Appi Bacteriol,1989,66:365-378.
  • 3[3]Schiffrin EJ,Rochat F,Link-Amster H,et al.Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.[J] J Dairy Sci,1994,78:491-497.
  • 4[4]Malin M,Suomalainen H,Saxelin M,et al.Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with lactobacillus GG [J].Ann Metab,1996,43:687-689.
  • 5[5]Hooper L,Falk P,Gordon J.Analyzing the molecular foundations of commensalisms in the mouse intestine [J].Curr Opin Microbiol,2000,3:79-85.
  • 6[6]Wostmann B.Immunology,including radiobiology and transplantation.In:Wostmann BS.ed.Germfree and gnotobiotic animal models[m].Boca Raton.FL:CRC Press.1996:101-25.
  • 7[7]Tuomola E,Ouwehand A,Salminen S.The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus.[J] FEMS Immunol Med Microbiol,1999,26:137-142.
  • 8[8]Salminen S,Isolaurie E,Salminen E.Clinical uses of probiotics for stabilizing the gut mucosal barrier:successful strains and future challenges [J].Antoine Van Leeuwenhoek,1996,70:347-358.
  • 9[9]Blomberg L,Henriksson A,Conway P.Inhibition of adhesion of Eschichia coli K 88to piglet ilealmucus by Lactriobacillus spp. [J] Appl Environ Microbiol,1993,59:34-39.
  • 10[10]Bernet MF,Brassart D,Neeser JR,et al.Lactobacillus acidophilus LA1 binds to culture human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacterial [J].Gut,1994,35:483-489.

共引文献117

同被引文献143

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部